A research group including Niigata University has revealed through a multi-center international study that the Polygenic Risk Score (PRS), which quantifies the genetic risk of Alzheimer's disease, is actually associated with the risk of developing Alzheimer's disease in many countries.
It is known that not only aging but also certain genetic variants are involved in the risk of developing Alzheimer's disease. The PRS quantifies the strength of an individual's genetic risk, but the relationship between the PRS and Alzheimer's disease has only been verified in certain countries.
Therefore, in this study, we conducted a large-scale validation study using the PRS of 17 Alzheimer's disease patients and 3 healthy elderly people from 2 countries, including 4 European countries, 28 East Asian countries, 122,840 African countries, 424,689 South American countries, India, and Australia. After integrating the results of the analysis of the relationship between the PRS and the risk of developing Alzheimer's disease in each country, we confirmed that the PRS was significantly higher in Alzheimer's disease patients than in healthy people, except in India and African countries, where the sample size was small. Furthermore, we found that the higher the PRS, the earlier the age at which Alzheimer's disease develops and the greater the changes in cerebrospinal fluid biomarkers.
The PRS used in this study is based on genetic variants identified by genome-wide association studies of populations of European ancestry. In this validation study, the PRS based on European ancestry was consistently associated with Alzheimer's disease risk across different ancestry populations, suggesting that previously reported genetic variants may explain many of the genetic components of Alzheimer's disease, regardless of ancestry. In the future, it is expected that PRS can be used to predict the risk of developing Alzheimer's disease and diagnose the disease early.
The researchers also investigated the relationship between PRS and other dementias (frontotemporal degeneration and Lewy bodies) in addition to Alzheimer's disease. As a result, they found that the effect of PRS was strongest in Alzheimer's disease and weaker in other dementias. In other words, the existence of genetic variants specific to Alzheimer's disease among various dementias is suggested, and the results are expected to be applied to the stratification of dementia based on genomic information.
Paper information: [Nature Genetics] Transferability of European-derived Alzheimer's Disease Polygenic Risk Scores across Multi-Ancestry Populations
